Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

E. Gabriela Chiorean, Daniel D. Von Hoff, Josep Tabernero, Robert El-Maraghi, Wen Wee Ma, Michele Reni, Marion Harris, Robert Whorf, Helen Liu, Jack Shiansong Li, Victoria Manax, Alfredo Romano, Brian Lu, David Goldstein

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences